Ultrasonic Tissue Ablation

For Integra Lifesciences

scroll to learn more


Electrical Engineering
Embedded Software Development


CE and CSA Mark approved

FDA and CE Mark cleared

CUSA® Clarity on market

Integra LifeSciences Receives FDA (510K) Clearance for Specific Neurosurgery Indication for CUSA® Clarity

Delivering on a tight timeline

Integra LifeSciences Corporation engaged with Sunrise to support the development of the next generation Ultrasonic Tissue Ablation system. Sunrise Labs designed and developed electronics and firmware for real-time control of an aspiration and irrigation subsystem on a fast-paced timeline.

Reduced surgery times and improved patient outcomes

CUSA® Clarity provides surgeons with more control when performing ablation procedures. This allows surgeons to differentially ablate tissue, leaving vasculature in place while removing surrounding structures.

Challenging accuracy requirements were complicated by an aspiration pump which would slowly wear out over time. Sunrise’s control system design anticipates and accounts for this known failure mode. Surgeon expectations were met for this industry-leading high-frequency surgical device. The combination of power and precision can reduce surgery times and improve patient outcomes, helping the product exceed sales expectations. The electronics were also designed with multiple modular boards, including a Windows Qseven module, to support future feature enhancements and extend product life. 

The resulting design meets IEC 60601-1 and IEC 60601-2-2 standards for the safety of high-frequency surgical equipment. CUSA® Clarity received CE mark and FDA 510(k) approval.

Let’s Work Together

Let us help you solve critical challenges to change people’s lives. Partner with our team of experts passionate about applying technology to improve lives.